Kwality Pharmaceuticals Ltd Nine Monthly Results

Gross Sales

254.52

215.19

182.23

392.14

Excise Duty

0

0

0

0

Net Sales

254.52

215.19

182.23

392.14

Other Operating Income

0

0

0

0

Other Income

1.15

1.25

1.48

1.91

Total Income

255.68

216.44

183.71

394.05

Total Expenditure

200.02

169.51

133.57

236.7

PBIDT

55.65

46.94

50.14

157.35

Interest

7.39

7.33

4.35

1.89

PBDT

48.27

39.61

45.78

155.46

Depreciation

13.2

14.49

10.53

7.93

Minority Interest Before NP

0

0

0

0

Tax

9.75

6.43

8.6

37.5

Deferred Tax

0

-0.61

-0.03

0.23

Reported Profit After Tax

25.32

19.3

26.68

109.8

Minority Interest After NP

-0.03

-0.05

-0.07

-0.05

Net Profit after Minority Interest

25.36

19.35

26.75

109.85

Extra-ordinary Items

0

0

0

0

Adjusted Profit After Extra-ordinary item

25.36

19.35

26.75

109.85

EPS (Unit Curr.)

24.41

18.47

25.3

105.49

Book Value (Unit Curr.)

0

0

0

0

Dividend (%)

0

0

0

0

Equity

10.38

10.38

10.38

10.38

Public Shareholding (Number)

0

0

0

0

Public Shareholding (%)

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

PBIDTM(%)

21.86

21.81

27.51

40.12

PBDTM(%)

18.96

18.4

25.12

39.64

PATM(%)

9.94

8.96

14.64

28